CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I) [Phase 1]
Summary
Phase 1 safety study of NStride Autologous Protein Solution for knee osteoarthritis has completed, with results posted in February 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED | Results posted: 2019-02-15